3 Clinical Stage Biotech Stocks That Should Be on Your Watchlist in 2015

Source: Celgene CorpBiotech stocks are notorious for their stratospheric gains and subterranean losses, especially clinical stage biotech stocks that develop promising, yet unproven, next-generation drugs. Those emerging biotech stocks may offer the potential for outsized returns, but they also carry significant risks. To help investors decide which of these clinical-stage companies may be worth considering in 2015, we asked three […]